APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dystrophin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dystrophin Industry Growth and Trends Forecast to 2032

Report ID 173987130122 December 202591 pages

Choose your research edition.

Industry ResearchDystrophin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dystrophin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Dystrophin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dystrophin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dystrophin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dystrophin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dystrophin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dystrophin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dystrophin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dystrophin include Pfizer Inc, Daiichi Sankyo Company Ltd, WAVE Life Sciences Ltd, Sarepta Therapeutics Inc, Nippon Shinyaku Co Ltd, Genethon SA, Editas Medicine Inc, BioMarin Pharmaceutical Inc and Asklepios BioPharmaceutical Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dystrophin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dystrophin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dystrophin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dystrophin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dystrophin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dystrophin Market by Company

Pfizer Inc

Daiichi Sankyo Company Ltd

WAVE Life Sciences Ltd

Sarepta Therapeutics Inc

Nippon Shinyaku Co Ltd

Genethon SA

Editas Medicine Inc

BioMarin Pharmaceutical Inc

Asklepios BioPharmaceutical Inc

Dystrophin Segment by Type

DS-5141

Biostrophin

BMBD-001

NS-065

Others

Dystrophin Segment by Application

Genetic Disorders

Musculoskeletal Disorders

Others

Dystrophin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dystrophin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dystrophin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dystrophin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dystrophin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dystrophin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DS-5141 Table 2. Major Company of Biostrophin Table 3. Major Company of BMBD-001 Table 4. Major Company of NS-065 Table 5. Major Company of Others Table 6. Global Dystrophin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Dystrophin Sales by Type (2021-2026) & (k units) Table 8. Global Dystrophin Sales Market Share in Volume by Type (2021-2026) Table 9. Global Dystrophin Sales by Type (2021-2026) & (US$ Million) Table 10. Global Dystrophin Sales Market Share in Value by Type (2021-2026) Table 11. Global Dystrophin Price by Type (2021-2026) & (US$/unit) Table 12. Global Dystrophin Sales by Type (2027-2032) & (k units) Table 13. Global Dystrophin Sales Market Share in Volume by Type (2027-2032) Table 14. Global Dystrophin Sales by Type (2027-2032) & (US$ Million) Table 15. Global Dystrophin Sales Market Share in Value by Type (2027-2032) Table 16. Global Dystrophin Price by Type (2027-2032) & (US$/unit) Table 17. North America Dystrophin Sales by Type (2021-2026) & (k units) Table 18. North America Dystrophin Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Dystrophin Sales by Type (2021-2026) & (k units) Table 20. Europe Dystrophin Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Dystrophin Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Dystrophin Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Dystrophin Sales by Type (2021-2026) & (k units) Table 24. Latin America Dystrophin Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Dystrophin Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Dystrophin Sales by Type (2021-2026) & (US$ Million) Table 27. Dystrophin Industry Trends Table 28. Dystrophin Industry Drivers Table 29. Dystrophin Industry Opportunities and Challenges Table 30. Dystrophin Industry Restraints Table 31. Global Dystrophin Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Dystrophin Revenue Market Share by Company (2021-2026) Table 33. Global Dystrophin Sales by Company (2021-2026) & (k units) Table 34. Global Dystrophin Sales Share by Company (2021-2026) Table 35. Global Dystrophin Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Dystrophin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Dystrophin Major Company Production Sites and Headquarters Table 38. Global Dystrophin Company, Product Type & Application Table 39. Global Dystrophin Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Dystrophin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Dystrophin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Dystrophin Sales by Region (2021-2026) & (k units) Table 44. Global Dystrophin Sales Market Share in Volume by Region (2021-2026) Table 45. Global Dystrophin Sales by Region (2021-2026) & (US$ Million) Table 46. Global Dystrophin Sales Market Share in Value by Region (2021-2026) Table 47. Global Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Dystrophin Sales by Region (2027-2032) & (k units) Table 49. Global Dystrophin Sales Market Share in Volume by Region (2027-2032) Table 50. Global Dystrophin Sales by Region (2027-2032) & (US$ Million) Table 51. Global Dystrophin Sales Market Share in Value by Region (2027-2032) Table 52. Global Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Dystrophin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Dystrophin Sales by Application (2021-2026) & (k units) Table 55. Global Dystrophin Sales Market Share in Volume by Application (2021-2026) Table 56. Global Dystrophin Sales by Application (2021-2026) & (US$ Million) Table 57. Global Dystrophin Sales Market Share in Value by Application (2021-2026) Table 58. Global Dystrophin Price by Application (2021-2026) & (US$/unit) Table 59. Global Dystrophin Sales by Application (2027-2032) & (k units) Table 60. Global Dystrophin Sales Market Share in Volume by Application (2027-2032) Table 61. Global Dystrophin Sales by Application (2027-2032) & (US$ Million) Table 62. Global Dystrophin Sales Market Share in Value by Application (2027-2032) Table 63. Global Dystrophin Price by Application (2027-2032) & (US$/unit) Table 64. North America Dystrophin Sales by Application (2021-2026) & (k units) Table 65. North America Dystrophin Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Dystrophin Sales by Application (2021-2026) & (k units) Table 67. Europe Dystrophin Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Dystrophin Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Dystrophin Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Dystrophin Sales by Application (2021-2026) & (k units) Table 71. Latin America Dystrophin Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Dystrophin Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Dystrophin Sales by Application (2021-2026) & (US$ Million) Table 74. Pfizer Inc Company Information Table 75. Pfizer Inc Business Overview Table 76. Pfizer Inc Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Pfizer Inc Dystrophin Product Portfolio Table 78. Pfizer Inc Recent Development Table 79. Daiichi Sankyo Company Ltd Company Information Table 80. Daiichi Sankyo Company Ltd Business Overview Table 81. Daiichi Sankyo Company Ltd Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Daiichi Sankyo Company Ltd Dystrophin Product Portfolio Table 83. Daiichi Sankyo Company Ltd Recent Development Table 84. WAVE Life Sciences Ltd Company Information Table 85. WAVE Life Sciences Ltd Business Overview Table 86. WAVE Life Sciences Ltd Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. WAVE Life Sciences Ltd Dystrophin Product Portfolio Table 88. WAVE Life Sciences Ltd Recent Development Table 89. Sarepta Therapeutics Inc Company Information Table 90. Sarepta Therapeutics Inc Business Overview Table 91. Sarepta Therapeutics Inc Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Sarepta Therapeutics Inc Dystrophin Product Portfolio Table 93. Sarepta Therapeutics Inc Recent Development Table 94. Nippon Shinyaku Co Ltd Company Information Table 95. Nippon Shinyaku Co Ltd Business Overview Table 96. Nippon Shinyaku Co Ltd Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Nippon Shinyaku Co Ltd Dystrophin Product Portfolio Table 98. Nippon Shinyaku Co Ltd Recent Development Table 99. Genethon SA Company Information Table 100. Genethon SA Business Overview Table 101. Genethon SA Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Genethon SA Dystrophin Product Portfolio Table 103. Genethon SA Recent Development Table 104. Editas Medicine Inc Company Information Table 105. Editas Medicine Inc Business Overview Table 106. Editas Medicine Inc Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Editas Medicine Inc Dystrophin Product Portfolio Table 108. Editas Medicine Inc Recent Development Table 109. BioMarin Pharmaceutical Inc Company Information Table 110. BioMarin Pharmaceutical Inc Business Overview Table 111. BioMarin Pharmaceutical Inc Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. BioMarin Pharmaceutical Inc Dystrophin Product Portfolio Table 113. BioMarin Pharmaceutical Inc Recent Development Table 114. Asklepios BioPharmaceutical Inc Company Information Table 115. Asklepios BioPharmaceutical Inc Business Overview Table 116. Asklepios BioPharmaceutical Inc Dystrophin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Asklepios BioPharmaceutical Inc Dystrophin Product Portfolio Table 118. Asklepios BioPharmaceutical Inc Recent Development Table 119. North America Dystrophin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Dystrophin Sales by Country (2021-2026) & (k units) Table 121. North America Dystrophin Sales Market Share by Country (2021-2026) Table 122. North America Dystrophin Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Dystrophin Sales Market Share Forecast by Country (2027-2032) Table 124. North America Dystrophin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Dystrophin Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Dystrophin Market Share by Country (2021-2026) Table 127. North America Dystrophin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Dystrophin Market Share Forecast by Country (2027-2032) Table 129. Europe Dystrophin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Dystrophin Sales by Country (2021-2026) & (k units) Table 131. Europe Dystrophin Sales Market Share by Country (2021-2026) Table 132. Europe Dystrophin Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Dystrophin Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Dystrophin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Dystrophin Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Dystrophin Market Share by Country (2021-2026) Table 137. Europe Dystrophin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Dystrophin Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Dystrophin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Dystrophin Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Dystrophin Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Dystrophin Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Dystrophin Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Dystrophin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Dystrophin Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Dystrophin Market Share by Country (2021-2026) Table 147. Asia-Pacific Dystrophin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Dystrophin Market Share Forecast by Country (2027-2032) Table 149. Latin America Dystrophin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Dystrophin Sales by Country (2021-2026) & (k units) Table 151. Latin America Dystrophin Sales Market Share by Country (2021-2026) Table 152. Latin America Dystrophin Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Dystrophin Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Dystrophin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Dystrophin Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Dystrophin Market Share by Country (2021-2026) Table 157. Latin America Dystrophin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Dystrophin Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Dystrophin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Dystrophin Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Dystrophin Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Dystrophin Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Dystrophin Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Dystrophin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Dystrophin Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Dystrophin Market Share by Country (2021-2026) Table 167. Middle East and Africa Dystrophin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Dystrophin Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Dystrophin Distributors List Table 172. Dystrophin Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Dystrophin Image Figure 2. Global Dystrophin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dystrophin Market Size (2021-2032) & (US$ Million) Figure 4. Global Dystrophin Sales (2021-2032) & (k units) Figure 5. DS-5141 Image Figure 6. Global DS-5141 Sales YoY Growth (2021-2032) & (k units) Figure 7. Biostrophin Image Figure 8. Global Biostrophin Sales YoY Growth (2021-2032) & (k units) Figure 9. BMBD-001 Image Figure 10. Global BMBD-001 Sales YoY Growth (2021-2032) & (k units) Figure 11. NS-065 Image Figure 12. Global NS-065 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Dystrophin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Dystrophin Market Share by Type 2025 VS 2032 Figure 17. North America Dystrophin Sales Market Share in Volume by Type in 2025 Figure 18. North America Dystrophin Sales Market Share in Value by Type in 2025 Figure 19. Europe Dystrophin Sales Market Share in Volume by Type in 2025 Figure 20. Europe Dystrophin Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Dystrophin Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Dystrophin Sales Market Share in Value by Type in 2025 Figure 23. Latin America Dystrophin Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Dystrophin Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Dystrophin Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Dystrophin Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Dystrophin Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Genetic Disorders Image Figure 30. Global Genetic Disorders Sales YoY Growth (2021-2032) & (k units) Figure 31. Musculoskeletal Disorders Image Figure 32. Global Musculoskeletal Disorders Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Dystrophin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Dystrophin Market Share by Application 2025 VS 2032 Figure 37. North America Dystrophin Sales Market Share in Volume by Application in 2025 Figure 38. North America Dystrophin Sales Market Share in Value by Application in 2025 Figure 39. Europe Dystrophin Sales Market Share in Volume by Application in 2025 Figure 40. Europe Dystrophin Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Dystrophin Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Dystrophin Sales Market Share in Value by Application in 2025 Figure 43. Latin America Dystrophin Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Dystrophin Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Dystrophin Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Dystrophin Sales Market Share in Value by Application in 2025 Figure 47. North America Dystrophin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Dystrophin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Dystrophin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Dystrophin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Dystrophin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Dystrophin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Dystrophin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Dystrophin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Dystrophin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Dystrophin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Dystrophin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Dystrophin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Dystrophin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Dystrophin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Dystrophin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Dystrophin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Dystrophin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Dystrophin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Dystrophin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Dystrophin Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Dystrophin Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Dystrophin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • DS-5141
  • Biostrophin
  • BMBD-001
  • NS-065
  • Others
Applications
  • Genetic Disorders
  • Musculoskeletal Disorders
  • Others
Companies covered
  • Pfizer Inc
  • Daiichi Sankyo Company Ltd
  • WAVE Life Sciences Ltd
  • Sarepta Therapeutics Inc
  • Nippon Shinyaku Co Ltd
  • Genethon SA
  • Editas Medicine Inc
  • BioMarin Pharmaceutical Inc
  • Asklepios BioPharmaceutical Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dystrophin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dystrophin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dystrophin Market by Type
  6. 1.3.1 DS-5141
  7. 1.3.2 Biostrophin
  8. 1.3.3 BMBD-001
  9. 1.3.4 NS-065
  10. 1.3.5 Others
  11. 1.4 Global Dystrophin Market Size by Type
  12. 1.4.1 Global Dystrophin Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Dystrophin Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Dystrophin Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Dystrophin Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Dystrophin Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Dystrophin Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Dystrophin Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Dystrophin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dystrophin Industry Trends
  2. 2.2 Dystrophin Industry Drivers
  3. 2.3 Dystrophin Industry Opportunities and Challenges
  4. 2.4 Dystrophin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dystrophin Revenue (2021-2026)
  2. 3.2 Global Top Players by Dystrophin Sales (2021-2026)
  3. 3.3 Global Top Players by Dystrophin Price (2021-2026)
  4. 3.4 Global Dystrophin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dystrophin Major Company Production Sites & Headquarters
  6. 3.6 Global Dystrophin Company, Product Type & Application
  7. 3.7 Global Dystrophin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dystrophin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dystrophin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dystrophin Tier 1, Tier 2, and Tier 3
4 Dystrophin Regional Status and Outlook
  1. 4.1 Global Dystrophin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dystrophin Historic Market Size by Region
  3. 4.2.1 Global Dystrophin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dystrophin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dystrophin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dystrophin Forecasted Market Size by Region
  7. 4.3.1 Global Dystrophin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dystrophin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dystrophin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dystrophin by Application
  1. 5.1 Dystrophin Market by Application
  2. 5.1.1 Genetic Disorders
  3. 5.1.2 Musculoskeletal Disorders
  4. 5.1.3 Others
  5. 5.2 Global Dystrophin Market Size by Application
  6. 5.2.1 Global Dystrophin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dystrophin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dystrophin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dystrophin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dystrophin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dystrophin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dystrophin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dystrophin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer Inc
  2. 6.1.1 Pfizer Inc Company Information
  3. 6.1.2 Pfizer Inc Business Overview
  4. 6.1.3 Pfizer Inc Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Inc Dystrophin Product Portfolio
  6. 6.1.5 Pfizer Inc Recent Developments
  7. 6.2 Daiichi Sankyo Company Ltd
  8. 6.2.1 Daiichi Sankyo Company Ltd Company Information
  9. 6.2.2 Daiichi Sankyo Company Ltd Business Overview
  10. 6.2.3 Daiichi Sankyo Company Ltd Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Daiichi Sankyo Company Ltd Dystrophin Product Portfolio
  12. 6.2.5 Daiichi Sankyo Company Ltd Recent Developments
  13. 6.3 WAVE Life Sciences Ltd
  14. 6.3.1 WAVE Life Sciences Ltd Company Information
  15. 6.3.2 WAVE Life Sciences Ltd Business Overview
  16. 6.3.3 WAVE Life Sciences Ltd Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 WAVE Life Sciences Ltd Dystrophin Product Portfolio
  18. 6.3.5 WAVE Life Sciences Ltd Recent Developments
  19. 6.4 Sarepta Therapeutics Inc
  20. 6.4.1 Sarepta Therapeutics Inc Company Information
  21. 6.4.2 Sarepta Therapeutics Inc Business Overview
  22. 6.4.3 Sarepta Therapeutics Inc Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sarepta Therapeutics Inc Dystrophin Product Portfolio
  24. 6.4.5 Sarepta Therapeutics Inc Recent Developments
  25. 6.5 Nippon Shinyaku Co Ltd
  26. 6.5.1 Nippon Shinyaku Co Ltd Company Information
  27. 6.5.2 Nippon Shinyaku Co Ltd Business Overview
  28. 6.5.3 Nippon Shinyaku Co Ltd Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nippon Shinyaku Co Ltd Dystrophin Product Portfolio
  30. 6.5.5 Nippon Shinyaku Co Ltd Recent Developments
  31. 6.6 Genethon SA
  32. 6.6.1 Genethon SA Company Information
  33. 6.6.2 Genethon SA Business Overview
  34. 6.6.3 Genethon SA Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Genethon SA Dystrophin Product Portfolio
  36. 6.6.5 Genethon SA Recent Developments
  37. 6.7 Editas Medicine Inc
  38. 6.7.1 Editas Medicine Inc Company Information
  39. 6.7.2 Editas Medicine Inc Business Overview
  40. 6.7.3 Editas Medicine Inc Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Editas Medicine Inc Dystrophin Product Portfolio
  42. 6.7.5 Editas Medicine Inc Recent Developments
  43. 6.8 BioMarin Pharmaceutical Inc
  44. 6.8.1 BioMarin Pharmaceutical Inc Company Information
  45. 6.8.2 BioMarin Pharmaceutical Inc Business Overview
  46. 6.8.3 BioMarin Pharmaceutical Inc Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BioMarin Pharmaceutical Inc Dystrophin Product Portfolio
  48. 6.8.5 BioMarin Pharmaceutical Inc Recent Developments
  49. 6.9 Asklepios BioPharmaceutical Inc
  50. 6.9.1 Asklepios BioPharmaceutical Inc Company Information
  51. 6.9.2 Asklepios BioPharmaceutical Inc Business Overview
  52. 6.9.3 Asklepios BioPharmaceutical Inc Dystrophin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Asklepios BioPharmaceutical Inc Dystrophin Product Portfolio
  54. 6.9.5 Asklepios BioPharmaceutical Inc Recent Developments
7 North America by Country
  1. 7.1 North America Dystrophin Sales by Country
  2. 7.1.1 North America Dystrophin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dystrophin Sales by Country (2021-2026)
  4. 7.1.3 North America Dystrophin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dystrophin Market Size by Country
  6. 7.2.1 North America Dystrophin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dystrophin Market Size by Country (2021-2026)
  8. 7.2.3 North America Dystrophin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dystrophin Sales by Country
  2. 8.1.1 Europe Dystrophin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dystrophin Sales by Country (2021-2026)
  4. 8.1.3 Europe Dystrophin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dystrophin Market Size by Country
  6. 8.2.1 Europe Dystrophin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dystrophin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dystrophin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dystrophin Sales by Country
  2. 9.1.1 Asia-Pacific Dystrophin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dystrophin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dystrophin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dystrophin Market Size by Country
  6. 9.2.1 Asia-Pacific Dystrophin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dystrophin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dystrophin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dystrophin Sales by Country
  2. 10.1.1 South America Dystrophin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dystrophin Sales by Country (2021-2026)
  4. 10.1.3 South America Dystrophin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dystrophin Market Size by Country
  6. 10.2.1 South America Dystrophin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dystrophin Market Size by Country (2021-2026)
  8. 10.2.3 South America Dystrophin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dystrophin Sales by Country
  2. 11.1.1 Middle East and Africa Dystrophin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dystrophin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dystrophin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dystrophin Market Size by Country
  6. 11.2.1 Middle East and Africa Dystrophin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dystrophin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dystrophin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dystrophin Value Chain Analysis
  2. 12.1.1 Dystrophin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dystrophin Production Mode & Process
  7. 12.2 Dystrophin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dystrophin Distributors
  10. 12.2.3 Dystrophin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst